Richard Shen
Managing Director & Interim Chief Executive Officer Sedgwick Yard & Endotope Biosciences
Seminars
Wednesday 23rd July 2025
Biopharma Business Development & Investors Panel: Secure the Financial Future of mRNA Technology Through Trusting Investor Partnerships
8:45 am
